41 related articles for article (PubMed ID: 12037430)
1. Anti-Hu antibody associated paraneoplastic neurological syndrome in a child with ganglioneuroblastoma: A rare case report and literature review.
Dai YL; Xiao L; Pan Z; He GQ; Gao J; Guo X; Huang Z
Medicine (Baltimore); 2024 May; 103(19):e38148. PubMed ID: 38728479
[TBL] [Abstract][Full Text] [Related]
2. T cell response to Hu-D peptides in patients with anti-Hu syndrome.
Rousseau A; Benyahia B; Dalmau J; Connan F; Guillet JG; Delattre JY; Choppin J
J Neurooncol; 2005 Feb; 71(3):231-6. PubMed ID: 15735910
[TBL] [Abstract][Full Text] [Related]
3. Dysautonomia in anti-Hu paraneoplastic neurological syndromes.
Villagrán-García M; Farina A; Arzalluz-Luque J; Campetella L; Muñiz-Castrillo S; Benaiteau M; Peter E; Dumez P; Wucher V; Dhairi M; Picard G; Rafiq M; Psimaras D; Rogemond V; Joubert B; Honnorat J
J Neurol; 2024 Jun; 271(6):3359-3369. PubMed ID: 38494470
[TBL] [Abstract][Full Text] [Related]
4. Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo).
Totland C; Bredholt G; Haugen M; Haukanes BI; Vedeler CA
Cancer Immunol Immunother; 2010 Feb; 59(2):231-7. PubMed ID: 19680650
[TBL] [Abstract][Full Text] [Related]
5. Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABA
Vogrig A; Pegat A; Villagrán-García M; Wucher V; Attignon V; Sohier E; Brevet M; Rogemond V; Pinto AL; Muñiz-Castrillo S; Peter E; Robert M; Picard G; Hopes L; Psimaras D; Terra A; Perrin C; Cogne D; Tabone-Eglinger S; Martinez S; Jury D; Valantin J; Gadot N; Auclair-Perrossier J; Viari A; Dubois B; Desestret V; Honnorat J
Ann Neurol; 2023 Dec; 94(6):1102-1115. PubMed ID: 37638563
[TBL] [Abstract][Full Text] [Related]
6. Proliferative response of peripheral blood mononuclear cells in anti-Hu antibody-associated patients with paraneoplastic neurological syndrome and their depressant effect on small cell lung cancer cells.
Yin L; Qu H; Chen Q
Mol Med Rep; 2015 Mar; 11(3):1595-600. PubMed ID: 25412252
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune responses in paraneoplastic neurological syndromes.
Zaborowski MP; Michalak S
Clin Dev Immunol; 2013; 2013():630602. PubMed ID: 24575143
[TBL] [Abstract][Full Text] [Related]
8. Progress in the management of paraneoplastic neurological disorders.
Sadeghian H; Vernino S
Ther Adv Neurol Disord; 2010 Jan; 3(1):43-52. PubMed ID: 21180635
[TBL] [Abstract][Full Text] [Related]
9. Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells.
Roberts WK; Deluca IJ; Thomas A; Fak J; Williams T; Buckley N; Dousmanis AG; Posner JB; Darnell RB
J Clin Invest; 2009 Jul; 119(7):2042-51. PubMed ID: 19509467
[TBL] [Abstract][Full Text] [Related]
10. Isolation of living neurons from human elderly brains using the immunomagnetic sorting DNA-linker system.
Konishi Y; Lindholm K; Yang LB; Li R; Shen Y
Am J Pathol; 2002 Nov; 161(5):1567-76. PubMed ID: 12414505
[TBL] [Abstract][Full Text] [Related]
11. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes.
Lladó A; Mannucci P; Carpentier AF; Paris S; Blanco Y; Saiz A; Delattre JY; Graus F
Neurology; 2004 Nov; 63(10):1947-9. PubMed ID: 15557520
[TBL] [Abstract][Full Text] [Related]
12. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer.
Verschuuren JJ; Perquin M; ten Velde G; De Baets M; Vriesman PB; Twijnstra A
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):353-7. PubMed ID: 10449558
[TBL] [Abstract][Full Text] [Related]
13. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
Douglas CA; Ellershaw J
Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression and serum anti-HuD antibody concentration in patients with paraneoplastic neurological syndromes.
Rauer S; Andreou I
Eur Neurol; 2002; 47(4):189-95. PubMed ID: 12037430
[TBL] [Abstract][Full Text] [Related]
15. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms.
Rauer S; Czygan M; Kaiser R
J Neurol; 2002 Mar; 249(3):285-9. PubMed ID: 11993527
[TBL] [Abstract][Full Text] [Related]
16. Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.
de Jongste AH; de Graaf MT; Martinuzzi E; van den Broek PD; Kraan J; Lamers CH; Mallone R; Gratama JW; Sillevis Smitt PA
Neuro Oncol; 2012 Jul; 14(7):841-8. PubMed ID: 22591661
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
